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A. Derom* and E. NoutDepartment of Surgery, Ziekenhuis Zeeuws-Vlaanderen, Terneuzen, The NetherlandsIntroduction. Anastomotic aneurysms are a late complication after arterial reconstruction. Current treatment usually
consists of open repair but we describe our experience with endovascular repair of femoral pseudoaneurysms.
Report. Six patients with seven femoral pseudoaneurysms were treated with percutaneously inserted endografts. Control
angiography confirmed immediate technical success in all cases. Exclusion of the para-anastomotic aneurysm was obtained
in all cases. No major complications or postoperative mortality were observed. No occlusions of the endografts occurred and
no endoleaks were noticed.
Discussion. Endovascular exclusion of femoral pseudoaneurysms is feasible and reliable. Long-term follow-up will
demonstrate if this approach in selected patients is justified.Keywords: Stent-graft; Para-anastomotic aneurysm; Endoprosthesis.Introduction
Anastomotic aneurysms are a late complication after
arterial reconstruction, and often remain a challenge to
the surgeon. The true incidence of these aneurysms is
not known, but is estimated between 2 and 8%.1–3
Complications include thrombosis, embolism, rupture
or compression on the adjacent structures.2,3 Current
treatment usually consists of open surgical resection of
the aneurysm, and interposition of a new graft.
Endovascular repair of femoral pseudoaneurysms is
less invasive, and fewer complications are described.1,
2,4Materials and Methods
Between September 1998 and December 2003, six
patients (five men; median age 77 years, range 69–79
years) with seven femoral pseudoaneurysms after
previous vascular surgery were treated with stent-
graft implantation. Two patients had undergoneing author. A. Derom, MD, Department of Surgery,
eeuws-Vlaanderen, Wielingenlaan 2, 4535 PA Terneu-
herlands.
: alex.derom@zzv.nl
0644 + 04 $35.00/0 q 2005 Elsevier Ltd. All rights reserprevious surgery for abdominal aortic aneurysm
(AAA), one patient for AAA and concomitant true
aneurysm of the common femoral artery, two patients
for aorto-iliac occlusive disease and one patient for
repeat endarterectomy and patch-plasty of the com-
mon femoral artery. One patient had bilateral femoral
pseudoaneurysms. The aneurysms ranged in diameter
from 30 to 140 mm (median 54 mm). The interval
between the initial operation and treatment of the
anastomotic aneurysm ranged from 3 months to 10
years (median 4.7 years). In the same time period, an
additional 13 surgical repairs of femoral pseudoaneur-
ysms were performed. The majority of these 13
patients were ASA II, with the higher-risk patients
being treated by endovascular procedure. Three
patients were classified as ASA III and two as ASA
IV because of severe cardiac disease, chronic obstruc-
tive pulmonary disease and renal failure. One patient
(ASA II), who was unwilling to undergo open surgical
repair of the femoral anastomotic aneurysm, also was
treated by endograft. One pseudoaneurysm in a high-
risk patient with bilateral pseudoaneurysms was
excluded from endovascular treatment for pseudoa-
neurysm on the left common femoral artery as this
patient had a patent superficial and profunda femoralEur J Vasc Endovasc Surg 30, 644–647 (2005)
doi:10.1016/j.ejvs.2005.05.028, available online at http://www.sciencedirect.com onved.
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repair. The contralateral pseudoaneurysm was treated
by endograft and was included in the present series.
Preoperative work-up consisted of ultrasound, CT-
scan and (calibrated) arteriography or MR-angiography.
Patients presenting with a femoral pseudoaneurysm
were only treated by endograft if the outflow consisted
of a single, undiseased vessel. The aim was to sacrifice
neither the superficial nor the profunda femoral artery
and all important side branches (Fig. 1).
All procedures were performed in the operating
room, usually under regional anaesthesia; general
anaesthesia was used in one patient. One dose of
antibiotics was administered prior to the procedure. A
percutaneous approach was used in all cases, using
11-F or 12-F introducers. The ipsilateral profunda
femoral artery was routinely used as access site for
treating pseudoaneurysm of the common femoral
artery. After puncture of the profunda femoral artery
under roadmapping and insertion of the sheath, 5000
units of heparin were administered.
The femoral pseudoaneurysms were treated using
either Hemobahn endografts (W. L. Gore and Associ-
ates) or by a tapered iliac excluder endograft.
Intraoperative angiogram confirmed exclusion of theFig. 1. Preoperative angiography showing a femoral
pseudoaneurysm.pseudoaneurysm in all cases. Postoperatively, manual
compression for about 20 min was accomplished by
the operating surgeon. Mechanical compression
devices were not used.
An oversizing in diameter of the endograft of 20–
30% was chosen. The proximal diameters ranged from
9 to 16 mm and distal diameters from 9 to 10 mm. The
length of the stent-graft was of lesser importance as the
proximal end of the endograft could be deployed high
up in the bypass graft, but an overlap of 1.5 cm was the
minimum requirement.
Patients already on anticoagulants continued their
treatment and aspirin was prescribed for other
patients.
Initial follow-up consisted of regular clinical
examinations and ultrasound. In one patient CT-scan
was performed annually because of a concomitant
pseudoaneurysm of the proximal aortic anastomosis.Results
Immediate technical success was obtained in all
cases. One stent-graft per procedure was used to
exclude the pseudoaneurysm. Angiography at the
end of the procedure confirmed exclusion of the para-
anastomotic aneurysm in all cases (Fig. 2). No
endoleak was observed, even on the delayed phase
of the angiogram. Median hospital stay was 6 days
(range 3–12 days).
No complications related to the procedure were
observed. One important groin haematoma developed
in the patient treated for ruptured anastomotic
aneurysm. There was no need for transfusion in the
elective cases. However, the patient treated for
ruptured pseudoaneurysm was given two units of
packed cells on the first postoperative day.2
No patients were lost to follow-up. The median
duration of follow-up was 18.6 months (range 6 weeks
to 4 years). At the time the present evaluation was
performed, four out of six patients in the group of the
femoral pseudoaneurysms had died from causes
unrelated to the treatment of the pseudoaneurysm.
Two patients died within the first 6 months following
the procedure, whereas the survival of the third was
2.5 years, and of the fourth 4 years. The two remaining
patients are still being followed. No endoleaks were
noticed and no stent-graft occlusions occurred. There
were no clinical signs of infection of endografts.
Patients treated by endograft for femoral pseudoa-
neurysm did not exhibit any stent-graft deterioration
on plain X-ray.Eur J Vasc Endovasc Surg Vol 30, 12 2005
Fig. 2. Control angiography after successful exclusion of the
pseudoaneurysm by insertion of an endograft.
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Femoral pseudoaneurysms are an underestimated
complication after bypass surgery.1,2 The traditional
treatment is interposition of a new bypass graft. The
procedure can be more difficult than the initial
operation due to the scarring tissue.2,3 Wound
infections have been reported in patients treated
surgically. There was no operative mortality associated
with surgical repair of 13 femoral pseudoaneurysms
during the same time period. However, a severe
wound infection occurred in three of these patients.
Moreover, in this group two patients presented with
groin seroma, requiring several drainages. No positive
cultures were observed.
As we still favour the surgical approach in low risk
patients and patients in which an endograft would
sacrifice the superficial or profound femoral artery,1,4
we initially restricted endovascular exclusion to
patients classified as ASA III or IV, having a limited
life expectancy. Since, a surgical approach in these
patients was considered risky, we favoured an
endovascular approach to relieve them from the
worry of having a pulsatile mass in the groin.
Moreover, surgeons were satisfied not to be confronted
with the acute complications of the pseudoaneurysmsEur J Vasc Endovasc Surg Vol 30, 12 2005in these high-risk patients. Only in the later phase did
we include a patient who was fit for open repair, who
was unwilling to undergo redo surgery.
In all the patients reported in this study the outflow
consisted of a healthy deep femoral artery which was
wide enough to accommodate an 11 or 12 F sheath.
However, puncture of the contralateral common
femoral artery and insertion of a flexible endoprosth-
esis (e.g. Hemobahn) by the cross-over technique,
through a previously placed cross-over sheath, also
would be feasible.
One of the major concerns in femoral pseudoaneur-
ysms, is the insertion of stent-grafts across the hip
joint.1 Indeed, failures have been reported in stents
across the knee, or in other motion sites like the
subclavian artery. Deformations, fractures and stent-
graft migration due to repetitive movement and
compression have been described.1 More recently,
however, only occlusions were described in the
exclusion of popliteal aneurysms with highly flexible
stent-grafts.5 In the present series, no specific advice
concerning flexion of the hip was given to the patients
as a majority had an impaired mobility or a limited life
expectancy.
To our knowledge, endovascular exclusion of
femoral pseudoaneurysms has been reported in only
three papers which dealt with a total of four patients,
including the ruptured femoral para-anastomotic
aneurysm in the present series.1,2,4 In these studies,
follow-up did not exceed 6 months,1,2 or was not
specified.4
We followed our patients by ultrasound or CT-scan.
The need for technical examinations at regular
intervals to monitor the occurrence of endoleaks
represents a potential disadvantage for the patient,
and can increase health care costs.
From the technical point of view, this study
illustrates that, in the short term, endografts can be
used to exclude a femoral para-anastomotic aneurysm.
The present series suggests that femoral para-anasto-
motic aneurysms can be excluded successfully and
occlusions are not to be expected. Further studies are
needed before the indication for endovascular
approach can be extended from high-risk patients to
all patients with single vessel outflow.Acknowledgements
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